Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


RDM researchers are leading one of the six new NIHR-BHF COVID-19 projects.

The project takes advantage of novel artificial intelligence (AI) techniques applied to CT chest scans to accurately measure the level of inflammation in the heart which is suspected to be a cause of severe responses to the virus. CT scans are now frequently used to estimate the involvement of the lungs and hearts of COVID-19 patients.

These AI methods were developed by Professor Charalambos Antoniades, who will lead the project with collaborators across the UK.

Linking their results to the data generated in the other Flagship Projects will guide the use of anti-inflammatory drugs in COVID-19 patients. This study will be strengthened by the availability of previous CT scans in many patients with existing heart disease and repeat CT scans after infection has subsided. This will allow a direct comparison of inflammation before, during and after infection to understand whether COVID-19 has lasting effects on heart health and therefore whether these patients should be treated more actively with medicines to reduce their cardiovascular risk.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

OCMR scans first study participants in new state-of the art MRI scanner

The Oxford Centre for Clinical Magnetic Resonance Research (OCMR) used its new 3 Tesla GE Premier MRI scanner to scan the first research study participants on 3rd November 2022.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.